Positioning the technology in the current therapeutic landscape
Searching for new causes of familial cancer
Challenging an old surgical standard
Algorithm distinguishes between benign and malignant masses
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Combination improves outcomes without increasing postoperative morbidity
Practice guidelines and key considerations
Tumor-infiltrating lymphocytes and natural killer cells
How these findings remove some clinical subjectivity, guide management
A deep dive into survival differences between pediatric and adolescent/young adult leukemia patients
“It’s better for everyone,” surgeon says.
Advertisement
Advertisement